| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 14,482,273 | 18,212,600 | 15,199,525 | | Cost of Revenue | 3,638,980 | 4,259,053 |
-
| | | Gross Profit | 10,843,293 | 13,953,547 | 15,199,525 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 5,127,468 | 6,822,844 | 9,357,581 | | Non Recurring | 675,916 | 342,518 | 253,998 | | Others | 2,652,929 | 3,261,061 | 2,684,995 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 2,386,981 | 3,527,124 | 2,902,952 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (207,030) | 2,375,202 | 1,208,205 | | Earnings Before Interest And Taxes | 2,103,031 | 5,902,326 | 3,916,368 | | Interest Expense | 613,725 | 762,511 | 816,911 | | Income Before Tax | 1,489,306 | 5,139,815 | 3,099,457 | | Income Tax Expense | 452,520 | 1,014,303 | 72,939 | | Minority Interest | (269,221) | (340,480) | (195,647) | | | | Net Income From Continuing Ops | 838,758 | 3,785,032 | 3,026,519 | | | Non-recurring Events | | Discontinued Operations | (67,919) | 141,697 | 47,196 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 770,839 | 3,926,729 | 3,073,714 | | Preferred Stock And Other Adjustments | (101,469) | (133,541) | (72,939) | | | Net Income Applicable To Common Shares | $669,369 | $3,793,187 | $3,000,776 |
|
0.34% Nasdaq 
Income Statement
